Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
Yoshihiro Kawaoka(University of Wisconsin–Madison), Tadaki Suzuki(National Institute of Infectious Diseases), Yuko Sakai(Institute of Medical Sciences), Ryuta Uraki(Tokyo University of Science), Tadashi Maemura(University of Wisconsin–Madison), Michiko Koga(Tokyo University of Science), Samantha Loeber(University of Wisconsin–Madison), Calvin Duong(Tokyo University of Science), Ryan Wright(University of Wisconsin–Madison), Hiroshi Ueki(Tokyo University of Science), Masao Hagihara(Eiju General Hospital), Atsuhiro Yasuhara(Tokyo University of Science), Emi Takashita(National Institute of Infectious Diseases), Seiya Ozono(National Institute of Infectious Diseases), Shun Iida(National Institute of Infectious Diseases), Hiroaki Mitsuya(National Institutes of Health), Daniel C. Douek(National Institutes of Health), Shin-ichiro Hattori(National Center for Global Health and Medicine), Shinya Yamamoto(Tokyo University of Science), Masayuki Hojo(Saitama International Medical Center), Seiya Yamayoshi(Tokyo University of Science), Kiyoko Iwatsuki‐Horimoto(Tokyo University of Science), Deanna Larson(Utah State University), Kenji Maeda(National Institute of Infectious Diseases), Michiko Ujie(Tokyo University of Science), Tetsuro Sato(Hokkaido University), Makoto Kuroda(University of Wisconsin–Madison), Moe Okuda(The University of Tokyo), Masaki Imai(University of Wisconsin–Madison), Maki Kiso(Tokyo University of Science), Norio Ohmagari(National Center for Global Health and Medicine), Michael Diamond(Washington University in St. Louis), Peter Halfmann(University of Wisconsin–Madison), Zhenlu Chong(Washington University in St. Louis), Takeya Tsutsumi(Netherlands Organisation for Applied Scientific Research), Yuri Furusawa(Tokyo University of Science), Hideki Hasegawa(University of California, Los Angeles), Eisuke Adachi(Tokyo University of Science), Jurika Murakami(Tokyo University of Science), Hiroshi Yotsuyanagi(The University of Tokyo), Sucheta Godbole(National Institutes of Health), Rong Li(Stowers Institute for Medical Research), Yanan Liu(East China Normal University), Makoto Saito(Tokyo University of Science), Seiichiro Fujisaki(National Institute of Infectious Diseases), Zhongde Wang(The Fourth People's Hospital of Zibo City), Shinji Watanabe(University of Miyazaki), Keiko Mitamura(Eiju General Hospital), Mutsumi Ito(Tokyo University of Science), Shohei Matsubara(Advanced Medical Research Institute)
Cited by 41
Related Papers
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
|Nature|2012|1.5k
The continued threat of emerging flaviviruses
|Nature Microbiology|2020|1.1k
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
|Nature Immunology|2020|997
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus
|Nature|2007|939
The broad-spectrum antiviral functions of IFIT and IFITM proteins
|Nature reviews. Immunology|2012|855